Published in Gastrointest Endosc on September 20, 2006
Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat Med (2014) 2.54
Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med (2013) 2.32
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med (2012) 1.83
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
Full-field optical coherence microscopy is a novel technique for imaging enteric ganglia in the gastrointestinal tract. Neurogastroenterol Motil (2012) 1.42
Optical endomicroscopy and the road to real-time, in vivo pathology: present and future. Diagn Pathol (2012) 1.04
Endoscopically guided spectral-domain OCT with double-balloon catheters. Opt Express (2010) 1.01
Motion artifacts associated with in vivo endoscopic OCT images of the esophagus. Opt Express (2011) 0.98
Interobserver agreement for the detection of Barrett's esophagus with optical frequency domain imaging. Dig Dis Sci (2013) 0.96
Fluorescence-guided optical coherence tomography imaging for colon cancer screening: a preliminary mouse study. Biomed Opt Express (2011) 0.96
Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study. Biomed Opt Express (2011) 0.91
Review of advanced imaging techniques. J Pathol Inform (2012) 0.90
Co-registered spectrally encoded confocal microscopy and optical frequency domain imaging system. J Microsc (2010) 0.88
Optical coherence tomography and Doppler optical coherence tomography in the gastrointestinal tract. World J Gastroenterol (2011) 0.86
Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc (2015) 0.79
Three-dimensional photoacoustic endoscopic imaging of the rabbit esophagus. PLoS One (2015) 0.79
Identification of the layered morphology of the esophageal wall by optical coherence tomography. World J Gastroenterol (2009) 0.78
Endoscopic Optical Coherence Tomography for Clinical Gastroenterology. Diagnostics (Basel) (2014) 0.78
Endoscopic imaging in Barrett's esophagus: current practice and future applications. Ann Gastroenterol (2012) 0.78
Rotational distortion correction in endoscopic optical coherence tomography based on speckle decorrelation. Opt Lett (2015) 0.76
The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy. Therap Adv Gastroenterol (2016) 0.75
Endoscopic modalities for the diagnosis of Barrett's oesophagus. United European Gastroenterol J (2015) 0.75
In vivo white light and contrast-enhanced vital-dye fluorescence imaging of Barrett's-related neoplasia in a single-endoscopic insertion. J Biomed Opt (2016) 0.75
Should there be light in the esophageal tunnel? An appraisal of optical coherence tomography in Barrett's esophagus. Gastrointest Endosc (2006) 0.75
Recent development of optical coherence tomography for preoperative diagnosis of esophageal malignancies. World J Gastrointest Endosc (2015) 0.75
What biomarkers explain about pterygium OCT pattern. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology (2001) 2.53
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90
Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol (2000) 1.85
Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol (1999) 1.76
Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol (2002) 1.51
Micromotor endoscope catheter for in vivo, ultrahigh-resolution optical coherence tomography. Opt Lett (2004) 1.42
Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol (1999) 1.40
Correlation of endoscopic optical coherence tomography with histology in the lower-GI tract. Gastrointest Endosc (2005) 1.39
Wide Tuning Range Wavelength-Swept Laser With Two Semiconductor Optical Amplifiers. IEEE Photonics Technol Lett (2005) 1.31
Optical coherence tomography in the gastrointestinal tract. Endoscopy (2000) 1.31
Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc (2002) 1.14
In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease. Clin Gastroenterol Hepatol (2004) 1.12
Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol (2000) 1.11
Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion (2003) 0.97
Ex vivo histology-correlated optical coherence tomography in the detection of transmural inflammation in Crohn's disease. Clin Gastroenterol Hepatol (2004) 0.87
Screening and surveillance for complications related to gastroesophageal reflux disease. Am J Med (2001) 0.87
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med (2010) 36.78
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med (2011) 16.94
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol (2009) 15.23
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33
Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett (2003) 10.17
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol (2012) 9.76
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. Sci Transl Med (2012) 8.41
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell (2009) 7.39
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res (2009) 7.35
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med (2009) 5.41
Comprehensive volumetric optical microscopy in vivo. Nat Med (2006) 5.19
Characterization of human atherosclerosis by optical coherence tomography. Circulation (2002) 5.04
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol (2002) 4.94
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res (2006) 4.83
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov (2012) 4.72
Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation (2003) 4.69
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging (2008) 4.49
In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett (2004) 4.43
Cystic neoplasms of the pancreas. N Engl J Med (2004) 3.89
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol (2005) 3.56
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature (2012) 3.51
Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48
Acquired resistance to crizotinib from a mutation in CD74-ROS1. N Engl J Med (2013) 3.42
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models. Cancer Cell (2012) 3.39
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol (2011) 3.27
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell (2005) 3.15
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96
Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94
Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg (2012) 2.85
Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics (2009) 2.79
Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol (2008) 2.74
Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med (2006) 2.71
Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med (2005) 2.67
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res (2013) 2.65
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res (2009) 2.62
Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med (2011) 2.60
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51
Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med (2006) 2.46
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med (2011) 2.44
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology (2014) 2.40
Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med (2006) 2.36
Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 2.35
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med (2013) 2.32
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (2010) 2.28